top of page

Get Molecular Testing - Canada (non-ON/non-QC)

As of July 1st, 2024, patients living with cholangiocarcinoma that reside outside of Ontario and Quebec will be able to access molecular testing from OncoHelix Labs, in partnership with the C3. OncoHelix-C3 molecular testing will use the 170 gene CGP "OncoHelix-2" panel, which can detect FGFR2 fusions and other DNA/RNA biomarkers (see below for full list).


Patients and treating physicians will receive a complete clinical report of Tier I (variants of strong clinical significance) and Tier II (variants of potential clinical significance) alterations in DNA and RNA biomarkers.

Important information:

  • Patients must be a "C3 Member" and have signed the C3 non-research consent

    • Please ask your patients to contact us if they haven't already​

  • The OncoHelix-C3​ test requisition form should be submitted to

    • Sample and Pathology details are on Page 2

Links for OncoHelix x C3:

Contact and Assistance Information:


For molecular testing requests from Alberta, please contact the first before submitting a test requisition form. 


*OncoHelix Labs is accredited by the College of Physicians and Surgeons of Alberta (CPSA) and performs all testing to CPSA Standards

bottom of page